METASTATIC COLORECTAL CANCER (MCRC)
Clinical trials for METASTATIC COLORECTAL CANCER (MCRC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CANCER (MCRC) trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER (MCRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a vitamin b derivative boost chemo for advanced colon cancer?
Disease control Recruiting nowThis study tests a new drug called arfolitixorin for people with metastatic colorectal cancer (cancer that has spread). The drug is a form of vitamin B that may make standard chemotherapy work better. About 90 participants will receive arfolitixorin along with usual chemo drugs, …
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: PHASE1, PHASE2 • Sponsor: Isofol Medical AB • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for liver metastases: immune booster combined with targeted chemo
Disease control Recruiting nowThis study tests whether adding an immune-boosting drug (PDS01ADC) to standard chemotherapy delivered directly to the liver can help people with colorectal, bile duct, or adrenal cancer that has spread to the liver. About 70 adults will receive the drug combination along with a s…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Real-World study tests fruquintinib for Tough-to-Treat colorectal cancer
Disease control Recruiting nowThis study is observing how well the drug fruquintinib works for people with metastatic colorectal cancer who have already tried standard treatments. About 150 participants in Germany will be treated as part of their normal care, and researchers will track tumor response, surviva…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a targeted drug keep working after cancer progresses? new trial aims to find out
Disease control Recruiting nowThis Phase 3 trial tests whether continuing cetuximab (a targeted antibody) with chemotherapy after first-line treatment stops working can improve outcomes in metastatic colorectal cancer. About 480 adults whose tumors have specific genetic markers (RAS and BRAF wild-type) will r…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: PHASE3 • Sponsor: University of Campania Luigi Vanvitelli • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Personalized cancer test could match patients to best drugs
Diagnosis Recruiting nowThis study is testing a new diagnostic test called µCAN that takes a small sample of a patient's tumor and grows it in the lab. The test then screens many drugs to see which ones kill the cancer cells best. The goal is to help doctors choose the right treatment for each person wi…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: NA • Sponsor: Oncosyne AS • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC
-
Exercise may boost Well-Being in advanced colorectal cancer patients
Symptom relief Recruiting nowThis study looks at whether a structured 18-week exercise program can improve health-related quality of life in people with metastatic colorectal cancer who are starting their first round of chemotherapy. About 150 adults will be randomly assigned to either the exercise group or …
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC